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Abstract 21 
In view of consumer health, it is desirable to promote the bioaccessibility of lipid-soluble compounds 22 
like carotenoids, while limiting the lipid intake. The objective of this work was to examine the relation 23 
between in vitro lipid digestion and β-carotene bioaccessibility of carrot-based model food emulsions 24 
containing water, 5% olive oil enriched with β-carotene (from carrots) and different concentrations 25 
(1-2-3-4%) of L-α-phosphatidylcholine (PHC), as an emulsifier. The lipid digestion (hydrolysis of 26 
triacylglycerols (TAGS) and incorporation of free fatty acids (FFAs) and monoacylglycerols (MAGs) in 27 
the micelles) and the β-carotene bioaccessibility (incorporation of β-carotene in the micelles) were 28 
studied after an in vitro digestion procedure wherein the stomach phase was mimicked for 2.0 h (37 29 
°C) and the small intestinal phase was mimicked for 1.0 h, 1.5 h and 2.0 h (37 °C) (both end-over-end 30 
rotations). As a consequence, not only the influence of the emulsifier concentration, but also the 31 
influence of the duration in the small intestinal phase was investigated in this study. The oil droplet 32 
size distributions of the emulsions at different stages of digestion were shown to be dependent on 33 
the phosphatidylcholine concentration, but independent on the duration in the small intestinal phase 34 
(1.0 h – 2.0 h). Furthermore, all TAGs were already hydrolysed into FFAs and MAGs after 1.0 h small 35 
intestinal phase and the incorporation of FFAs and MAGs into micelles seemed to reach a maximum 36 
for all emulsions (approximately 26.5%), independent on the phoshpatidylcholine concentration and 37 
thus on the particle size distributions. Finally, the β-carotene bioaccessibility increased with 38 
increasing phosphatidylcholine concentration, ranging from 33.2% to 79.8% for a 1% and 4% PHC 39 
emulsion respectively. No significant differences in β-carotene bioaccessibility were however noticed 40 
for the different durations in the small intestinal phase tested. In conclusion, a higher 41 
phosphatidylcholine concentration in emulsions leads to higher β-carotene bioaccessibility while the 42 
incorporation of lipids into micelles did not increase. 43 
 44 
 45 
1 Introduction  46 
Consumers are becoming more and more aware of the importance of a balanced and healthy diet. 47 
This balanced and healthy diet includes besides fruit and vegetables, containing carotenoids, also a 48 
low amount of fat or oil. Carotenoids (e.g. β-carotene) are a group of lipid-soluble bioactive 49 
compounds which seem to have a positive impact on human health, because of their antioxidant 50 
capacity or immune system enhancing properties. In addition, carotenoids such as β-carotene act as 51 
provitamin A (Dutta, Chaudhuri, & Chakraborty, 2005; Fernández-Garcia et al., 2012). Mammals 52 
however need to obtain carotenoids from their diet, hence a good level of absorption or 53 
bioavailability from the food is desirable. The bioavailability is the fraction of the ingested 54 
(micro)nutrient that is available for utilization in physiological functions and for storage in the body. 55 
It is partially determined by its bioaccessibility, which is in case of a lipid soluble (micro)nutrient, the 56 
fraction of the ingested (micro)nutrient that is incorporated into micelles and thus becomes available 57 
for absorption in the body (Hedren, Diaz, & Svanberg, 2002; Palafox-Carlos, Ayala-Zavala, & 58 
Gonzalez-Aguilar, 2011). Bioavailibility is dependent on several factors, grouped in the word 59 
“SLAMENGHI”. The letters of “SLAMENGHI” stand for Species of carotenoids, molecular Linkage, 60 
Amount of carotenoids consumed in a meal, Matrix in which the carotenoid is incorporated, Effectors 61 
of absorption and bioconversion, Nutrient status of the host, Genetic factors, Host-related factors 62 
and Interactions (Castenmiller & West, 1998). Because carotenoids are lipophilic, the presence of 63 
lipids constitute an effector of absorption (E) (Castenmiller & West, 1998; Hedren et al., 2002). In this 64 
context, it has already been demonstrated that the absorption of carotenoids increases by adding 65 
lipids to the diet, hence a minimum amount of lipids is needed for the carotenoid absorption 66 
(Castenmiller & West, 1998). Over-consumption of lipids on the other hand can lead to obesity and 67 
increasing risks of cardiovascular diseases (Simopoulos, 1999; McClements & Decker, 2009).  68 
To understand and control the absorption of lipophilic micronutrients, knowledge about lipid 69 
digestion is needed. Lipid digestion can be divided into two steps, (i) the hydrolysis and (ii) 70 
micellization of the dietary lipids. Specifically, triaceylglycerols (TAGs) (like triolein, mostly present in 71 
olive oil) are hydrolyzed  into diacylglycerols (DAGs), monoacylglycerols (MAGs) and free fatty acids 72 
(FFAs), after which the MAGs and FFAs can be incorporated into micelles. Micelle formation is 73 
essential for the absorbtion in the enterocytes. Micelles contain, besides MAGs and FFAs, bile salts, 74 
phospholipids and lipid-soluble compounds, like β-carotene (Hofmann & Borgstrom, 1962; Yonekura 75 
& Nagao, 2007). Hence the ingestion and hydrolysis of lipids (resulting in MAGs and FFAs) along with 76 
carotenoids is thought to be essential for the absorption of carotenoids (van het Hof, West, 77 
Weststrate, & Hautvast, 2000). The rate of hydrolysis by lipase can depend on different factors. The 78 
oil droplet size for instance influences the area of lipid surface available to lipase. Moreover, the 79 
composition of the droplet surfaces and the rheological properties of the surrounding medium are 80 
important as well. Very small oil droplets covered with surfactants which are strongly bound to the 81 
oil droplets in a viscous medium will be hydrolysed slower by lipase than larger oil droplets covered 82 
with less bound surfactants in a low viscous medium for example (McClements & Decker, 2009). 83 
Finally, the rate of micelle formation can be affected by the surfactant type and concentration, the 84 
viscosity of the surrounding medium and the amount of hydrolysed products amongst others 85 
(McClements & Decker, 2009).  86 
In view of consumer health, it is desirable to promote the bioaccessibility of lipid-soluble compounds 87 
like carotenoids, while on the other hand the lipid intake should be reduced. As a consequence, 88 
knowledge on the link between lipid digestion and β-carotene bioaccessibility is important and can 89 
be used to design food systems in which these properties are controlled. Specifically to understand 90 
this link, simple model emulsions with a low amount of lipids and different properties, like different 91 
oil droplet size (distributions) can be used as study object. The oil droplet size (distribution) seems in 92 
turn to influence the activity of lipase (Armand et al., 1996; Mun, Decker, & McClements, 2007) and 93 
is expected to influence the lipid digestion and β-carotene bioaccessibility therefore. To prepare 94 
emulsions with different oil droplet size distributions, different concentrations of emulsifiers can be 95 
utilised because the emulsifier concentration is expected to influence the oil droplet size distribution 96 
(Mun et al., 2007; Hur, Decker, & McClements, 2009). As emulsifier, a natural, harmless and useful 97 
surfactant, phosphatidylcholine, was choosen. Phosphatidylcholine is the major membrane 98 
phospholipid in mammalian cells, critical for the membrane structure and function (Gennis, 1989; 99 
Venturoli, Sperotto, Kranenburg, & Smit, 2006). Besides this, phosphatidylcholine is an important 100 
source of choline, an essential nutrient, in the body, which is needed for vital functions like the 101 
synthesis of cell signaling molecules and neurotransmitters involved in muscle control and memory 102 
(Zeisel, 2006; Sanders & Zeisel, 2007)   103 
 In the present work, the influence of the L-α-phosphatidylcholine concentration on the in vitro lipid 104 
digestion and β-carotene bioaccessibility in low fat emulsion systems was investigated. To investigate 105 
lipid digestion, lipid extraction and quantification was optimized and implemented, based on a 106 
method of Helbig et al. (2012). Furthermore, the particle size distributions of the digests at different 107 
stages of digestion as well as the influence of the duration in the small intestinal phase on lipid 108 
digestion and β-carotene bioaccessibility were investigated. In this way, more information about 109 
lipase activity, micelle formation and β-carotene incorporation could be obtained. Finally, the link 110 
between the micellar lipid incorporation and the β-carotene bioaccessibility was evaluated.  111 
2 Materials and methods 112 
2.1 Materials 113 
Fresh carrots (Daucus carota cv. Nerac) were purchased in a local shop in Belgium and stored at 4 °C. 114 
Olive oil (extra virgin) was kindly donated by Vandemoortele (Ghent, Belgium). All chemicals and 115 
reagents were from Sigma Aldrich, except for NaCl, HCl, urea, anhydrous sodium sulphate and 116 
ethanol (from VWR); CaCl2.2H20, NH4Cl and MgCl2 (from Merck); hexane, sulphuric acid and acetone 117 
(from Chem Lab); glucose and NaHCO3 (from Fisher Scientific); heptane (from Fluka); KCl (from MP 118 
Biomedicals) and diethylether (from Riedel-De Haën). All chemicals and reagents were of analytical 119 
grade. The phosphatidylcholine Assay Kit is from Cayman Chemical Company.  120 
2.2 Preparation of β-carotene enriched oil-in-water emulsions 121 
Olive oil enriched with β-carotene (from carrots) was prepared according to the procedure described 122 
by Verrijssen et al. (2014). Emulsions were prepared by blending (10 min, ultra turax (Waring 123 
Commercial, Torrington, CT, USA))  5% (w/w) of this enriched oil with demineralized water, in which 124 
1, 2, 3 or 4% (w/w) L-α-phosphatidylcholine (PHC) was dissolved. After blending, the emulsions were 125 
homogenized (Stansted Fluid Power, Pressure cell homogeniser, U.K.) at 100 MPa using a single 126 
cycle. The pH was adjusted to 6.0 using a (1 M) sodium hydroxide solution. The different emulsions 127 
are further indicated as “1% PHC emulsion”, “2% PHC emulsion”, “3% PHC emulsion” and “4% PHC 128 
emulsion”. Emulsions were prepared in duplicate. Each emulsion was independently submitted to 129 
the in vitro digestion procedure. 130 
2.3 In vitro digestion of β-carotene enriched emulsions 131 
2.3.1 Digestion model 132 
Digests were passed through a two-step static in vitro digestion model based on the method 133 
described by Versantvoort et al. (2005). The first step in the digestion method is the simulation of the 134 
stomach phase by addition of 12 ml stomach juice (pH 1.3), which contains mainly electrolytes, 135 
bovine serum albumine, pepsin and mucin (Versantvoort, Oomen, Van de Kamp, Rompelberg, & Sips, 136 
2005) to 6 g emulsion and rotating this mixture 2.0 h end-over-end (40 rpm) at 37°C. After the 137 
stomach phase, the intestinal phase is simulated by mixing (end-over-end, 40 rpm) 12 ml duodenal 138 
juice, 6 ml bile juice and 2 ml 1 M bicarbonate with the emulsion and stomach juice (37°C). The 139 
duration of the small intestinal phase was 1.0 h, 1.5 h and 2.0 h (further indicated as “SIP 1.0 h”, “SIP 140 
1.5 h” and  “SIP 2.0 h” respectively). To minimize the influence of light and oxygen, the samples were 141 
kept in the dark during the whole digestion procedure and the headspace of the tubes was flushed 142 
with nitrogen prior to each incubation step.  143 
2.3.2 Particle size distribution during digestion 144 
The particle size and particle size distribution of the samples were measured by laser diffraction 145 
(Beckman Coulter Inc, LS 13 320, Miami, Florida) during digestion, i.e. before digestion, after the 146 
stomach phase (2.0 h) and after the small intestinal phase (SIP 1.0 h, SIP 1.5 h and SIP 2.0 h). The 147 
sample was poured into a stirred tank, filled with deionized water, and pumped into the 148 
measurement cell wherein the laser light (wavelength main illumination source: 750 nm; 149 
wavelengths halogen light for Polarization Intensity Differential Scattering (PIDS): 450 nm, 600 nm, 150 
900 nm) is scattered by particles in the sample. All analyses were carried out in duplicate.  151 
Besides laser diffraction, microscopy pictures were taken to visualize the microstructure of the 152 
samples. This was done using a light microscope (Olympus BX-41) equipped with an Olympus XC-50 153 
digital camera (Olympus, Opticel Co. Ltd., Tokyo, Japan). 154 
2.3.3 Lipid digestion  155 
The amount of lipids was measured before digestion (in the initial emulsions), after the small 156 
intestinal phase (SIP 1.0 h, SIP 1.5 h and SIP 2.0 h) and in the micelle fraction (collected after the 157 
small intestinal phase). As a consequence, not only the release of  FFAs and MAG from TAG, but also 158 
their incorporation in the micelle fraction could be investigated. The micelle fraction was in this 159 
respect collected after the small intestinal phase (SIP 1.0 h, SIP 1.5 h and SIP 2.0 h) by 160 
ultracentrifugation (165,000 g, 1 h and 5 min, 4 °C). To identify and quantify the amount of TAG, DAG 161 
(diacylglycerol), MAG and FFA in the different types of samples, a procedure was implemented and 162 
optimised based on the procedure of Helbig et al. (2012). Basically, some modifications to the 163 
extraction step and the quantification step were applied. In the first step of this procedure, the 164 
extraction step, 2 ml sample was taken and poured into an extraction mix, containing 2 ml ethanol, 3 165 
ml diethylether-heptane (DEE-Hep, 1:1 v/v) and 0.2 ml 2.5 M sulphuric acid. This mixture was 166 
vortexed for 2 min after which it was mixed (end-over-end) for 30 min and centrifuged for 5 min at 167 
500 g (20 °C). The upper layer was collected in a new tube. 1 ml of DEE-Hep was added to the lower 168 
layer and the mixture was vortexed (1 min), mixed end-over-end (15 min) and centrifuged again. The 169 
upper layer was again collected and added to the previous upper layer. 100 mg anhydrous sodium 170 
sulphate and an internal standard (50 µl trilaurin (0.2 g / 5 ml DEE-Hep) for the quantification of TAGs 171 
and 100 µl methyl heptadecanoate (0.04 g / 5 ml DEE-Hep) for the quantification of MAGs and FFAs) 172 
were added to the collection of the two upper layers, after which the whole volume was brought to 5 173 
ml with DEE-Hep. The type and concentration of internal standard were chosen so to not interfere 174 
with the compounds present in the sample and to have an abundance comparable to the lipids in the 175 
sample.   176 
The second step was the identification and quantification of the compounds with the GC-MS. In the 177 
GC (Agilent Technologies, 6890N Network GC System, United States) with column VF-ht, UltiMetal 178 
(Varian BV, Middelburg, Netherlands), 0.2 µl sample was injected splitless. The oven temperature 179 
was programmed at 80 °C (1 min) and increased with 6 °C.min-1 to 400 °C (2 min). For the detection 180 
of the compounds, a MS-system (Agilent Technologies, 5973 inert Mass Selective Detector, United 181 
States), has been used. Standard curves were used to quantify the different compounds based on the 182 
amount internal standard added.  183 
The 
𝐿𝑀
𝐿𝑆𝐼𝑃
-value was calculated which is the the amount of lipids (FFAs and MAGs) in the micelle 184 
fraction (after digestion) per g initial emulsion (LM) relatively to the amount of lipids (FFAs and MAGs) 185 
after the small intestinal phase (SIP) per g initial emulsion (LSIP) . Both values were calculated using 186 
the standard curves. Because the LSIP-value was the same for all samples (results not shown) and no 187 
DAG and TAG were available in the digested samples, the 
𝐿𝑀
𝐿𝑆𝐼𝑃
-value is representative for the 188 
incorporation of lipids in the micelles. 189 
2.3.4 In vitro β-carotene bioaccessibility   190 
The in vitro β-carotene bioaccessibility (
𝐵 
𝐶
) was calculated as the amount of β-carotene in the 191 
micelles after digestion per g initial emulsion (B) relative to the initial amount of β-carotene in the 192 
digest per g initial emulsion (C) according to the procedure described by Verrijssen et al. (2014). This 193 
value thus represents the incorporation of β-carotene into the micelles. All analyses were carried out 194 
in triplicate.  195 
2.3.5 Phosphatidylcholine concentration  196 
The phosphatidylcholine concentration was quantified before digestion, after the small intestinal 197 
phase and in the micellar fraction using the Phosphatidylcholine Assay Kit (Cayman Chemical 198 
Company, Michigan, USA). In this kit, the quantification is done by using phospholipase D, choline 199 
oxidase and peroxidase to hydrolyze and color the phosphatidylcholine present. The absorbance of 200 
this color, a blue dye, is measured with a plate reader at 600 nm. By using a standard curve, plotting 201 
the absorbance in function of the concentration phosphatidylcholine (from 0 to 150 mg 202 
phosphatidylcholine per dl sample), the concentration could be calculated. Dilutions of the samples 203 
were made to not exceed the concentrations of the standard curve.  204 
2.3.6 Statistical analysis 205 
Differences in mean 
𝐿𝑀
𝐿𝑆𝐼𝑃
-value and β-carotene bioaccessibility were analyzed using one-way anova 206 
and the Tukey’s Studentized Rand Post-hoc Test (Statistical Software Package SAS, version 9.2., Cary, 207 
N.C., U.S.A.). The level of significance was 95% (P<0.05). 208 
3 Results and discussion 209 
3.1 Particle size distribution of emulsions during in vitro digestion 210 
3.1.1 Initial emulsions 211 
The particle size distributions of the different initial emulsions are shown in Fig. 1. It can be 212 
concluded that increasing the phosphatidylcholine concentration results in a decrease of oil droplet 213 
size. The median decreases namely from 1.20 ± 0.08 µm  to 0.84 ± 0.01 µm, 0.61 ± 0.05 µm and 0.46 214 
± 0.12 µm for a 1%, 2%, 3% and 4% PHC emulsion respectively. Moreover, the width of the oil droplet 215 
size distributions decreased with increasing phosphatidylcholine concentration. Mun et al. (2007) 216 
and Hur et al. (2009) found as well that oil droplet size and size distribution decrease with an 217 
increase in the emulsifier concentration (tested with lecithine and Tween 20). It has to be noted 218 
however that differences in oil droplet size and size distribution are relatively small probably due to 219 
the high pressure homogenization step during the preparation of the emulsions.   220 
In Fig. 2, microscopic images confirm the trends found in the particle size distributions of the 221 
different emulsions (Fig. 1). Although (high pressure) homogenization is applied, some large oil 222 
droplets still exist in the 1% PHC emulsion and the emulsion is more heterogeneous compared to the 223 
4% PHC emulsion (Figs. 2a and b). Probably some oil droplet coalescence appeared immediately after 224 
applying the high pressure (short-term stability) because the interfacial layer (between oil and water) 225 
was not fully occupied with phosphatidylcholine. The emulsion is however stable and does not 226 
changed in time (long-term stability) (McKenna, 2003). Fig. 2b shows that the 4% PHC emulsion 227 
contains small oil droplets only and is more homogeneous.  228 
3.1.2 Digested emulsions 229 
The particle size distribution of the four emulsions was also examined at different stages of digestion. 230 
To understand the digestion, next to the particle sizes of the initial emulsions, also the particle sizes 231 
after the stomach phase and after the small intestinal phase are important. The particle size after the 232 
stomach phase determines the surface area where lipase will interact whereas the particle size 233 
distribution resulting after the small intestinal phase can give some information on the presence of 234 
aggregated material and/or remaining oil droplets. In addition, the influence of the 235 
phosphatidylcholine concentration on the particle size distribution during digestion is of interest.   236 
In Fig. 3, the particle size distributions before digestion, after the stomach phase and after the small 237 
intestinal phase (SIP 1.0 h, SIP 1.5 h and SIP 2.0 h) are given for the 1% PHC emulsion (Fig. 3a) and the 238 
4% PHC emulsion (Fig. 3b). Microscopic images of oil droplets after the stomach phase are given for 239 
the 1% PHC emulsion and the 4% PHC emulsion in Figs. 4a and b respectively. The results on the 240 
particle size distributions of all emulsions showed an increase in particle size after the stomach phase 241 
compared to the initial size (before digestion), except for the 4% PHC emulsion (Fig. 3b) (results of 242 
2% and 3% PHC emulsion not shown). Oil droplet clustering (seen in the microscopic picture, Fig. 4a) 243 
due to mucin present in the stomach phase can be the reason for this increase in particle size in the 244 
1%, 2% and 3% PHC emulsion. Mucin, a highly glycosylated protein, can promote oil droplet 245 
flocculation which may be due to a bridging or depletion mechanism (Vingerhoeds, Blijdenstein, 246 
Zoet, & van Aken, 2005; Singh & Sarkar, 2011). It can be hypothesized that the high 247 
phosphatidylcholine concentration in the 4% PHC emulsion hinders this oil droplet clustering (Fig. 4b) 248 
by interacting with mucin or by protecting the oil droplets from mucin. At the low pH of the stomach 249 
phase, repulsion may occur between the positive charge of phosphatidylcholine and the positively 250 
charged mucins.  Differences in particle size distribution after the stomach phase, and so before 251 
small intestinal phase, resulting in differences in oil-water-interfaces, are expected to influence the 252 
lipase activity (McClements & Decker, 2009).  253 
Although the duration in the small intestinal phase does not seem to influence the particle size (Figs. 254 
3a and b), a remarkable difference has been noted between the different emulsions. By increasing 255 
the phosphatidylcholine concentration, the particle size increased after the small intestinal phase. 256 
This might be explained as follow. By digesting the oil droplets in the small intestinal phase and/or by 257 
adding other surfactant molecules (present in the small intestinal juice), phosphatidylcholine might 258 
come into the aqueous phase of the sample. The higher the phosphatidylcholine concentration, the 259 
more phosphatidylcholine will be present in this aqueous phase. Phosphatidylcholine is however an 260 
amphiphilic molecule with hydrophobic and hydrophilic groups. For this reason, in a bulk aqueous 261 
phase, phosphatidylcholine may form aggregates with proteins, bile acids or hydrolysis products 262 
(Mun et al., 2007; Hur et al., 2009) with their hydrophobic tail in the core and the hydrophilic head to 263 
the surrounding aqueous phase. Salvia-Trujillo et al. (2013a) found however that the size of micelles 264 
(containing bile acids, hydrolysis products and other fat-soluble compounds) is between 1-1000 nm. 265 
The interaction between phosphatidylcholine and proteins may explain the larger particles measured 266 
by laser diffraction (size around 30 µm) (Fig. 3b).  267 
3.2 Lipid digestion  268 
In  the initial emulsions, three kind of TAGs were detected, i.e. glycerol bound with three C18-fatty 269 
acids (mostly oleic acid, linoleic acid, stearic acid or vaccenic acid), glycerol bound with two C18-fatty 270 
acids and one C16-fatty acid (mostly palmitic acid or palmitoleic acid) and glycerol bound with two 271 
C16-fatty acids and one C18-fatty acid (results not shown). These results are in agreement with the 272 
fatty acid (FA) composition of the olive oil (extra virgin) as determined by Vandermoortele (Ghent, 273 
Belgium) (78.5% oleic acid, 10.6% palmitic acid, 5.0% linoleic acid, 3.7% stearic acid, 1.0% palmitoleic 274 
acid and other fatty acids < 1.0%).   275 
After the stomach phase, the same lipid composition was found compared to the initial composition 276 
(results not shown), which is explained by the fact that no hydrolyzing enzymes (such as gastric 277 
lipase) were added in the stomach phase so the composition of lipids did not change. 278 
After the small intestinal phase (1.0 h, 1.5 h and 2.0 h) on the other hand, all TAGs were hydrolyzed 279 
to MAGs and FFAs. By comparing the composition of the FAs in the TAGs of the initial emulsions and 280 
the FFAs in the small intestinal phase with the FFAs incorporated in the micelles, it was noticed that 281 
palmitic acid (hexadecanoic acid, C16), a saturated fatty acid, was not incorporated into the micelles. 282 
In this context, Karupaiah and Sundram (2007) found that long chain saturated FFAs are poorly 283 
absorbed because they would form a kind of soap in the small intestinal phase due to their strong 284 
electrostatic interactions wit cationic multivalent mineral ions (for example calcium or magnesium, 285 
present in digestion juices) and due to their high melting point. Because of the controversy about 286 
saturated fatty acids in a diet due to their hypercholesterolaemic-atherogenic potential (Connor et 287 
al., 1986; Ulbricht & Southgate, 1991), it is thus an important finding that saturated acids, such as 288 
palmitic acid, might be less incorporated into micelles.  289 
Fig. 5 shows that there is no significant difference between the incorporation of lipids into the 290 
micelles (indicated as the 
𝐿𝑀
𝐿𝑆𝐼𝑃
-value), nor for the different phosphatidylcholine concentrations in the 291 
emulsions nor between the different durations in the small intestinal phase. After 1.0 h SIP already 292 
all TAGs were hydrolysed into MAGs and FFAs (LSIP-value was always the same and no DAGs or TAGs 293 
were present in the small intestinal phase) and incorporation of lipids in the micelles reached an 294 
equilibrium (LM-value is also always the same, for all durations and for all different emulsions). It 295 
seems that a maximum (of approximately 26.5%) has been reached and that the particle size is not 296 
the (main) influencing factor. It should be noted that on the one hand the differences in initial 297 
particle size between the different emulsions were rather small in this experiment which may have 298 
caused the apparent lack of influence of oil droplet size, although larger differences in particle size 299 
were noted between the different emulsions after the stomach phase (Fig. 4). And on the other 300 
hand, that measuring particle sizes and particle size distributions in systems, containing e.g. oil 301 
droplets, micelles, non-digested fat and enzymes is complex. 302 
3.3 In vitro β-carotene bioaccessibility                     303 
From Fig. 6, it can be observed that the β-carotene bioaccessibility increases with increasing 304 
phosphatidylcholine concentration, going from an average  
𝐵
𝐶
 –value of 33.2% (1% PHC emulsion) to 305 
79.8% (4% PHC emulsion). No significant differences in β-carotene bioaccessibility were however 306 
noticed for different durations in the small intestinal phase. From the results of the oil droplet size 307 
distributions (at different stages of digestion) (Figs. 1 and 3), it was expected that the 4% PHC 308 
emulsion would result in a higher β-carotene bioaccessibility because smaller oil droplet size, 309 
observed after the stomach phase in the 4% PHC emulsion, can improve the lipase-activity due to 310 
their higher surface area compared to larger oil droplets (Armand et al., 1996; Salvia-Trujillo, Qian, 311 
Martin-Belloso, & McClements, 2013b). Improved lipase-activity in turn leads to more hydrolysis 312 
products (MAGs and FFAs) which can improve micelle-formation. Finally, those micelles can 313 
incorporate β-carotene hence making this lipophilic micronutrient accessible for absorption in the 314 
small intestinal phase. Increasing the formation of micelles is thus supposed to increase the β-315 
carotene bioaccessibility (Salvia-Trujillo et al., 2013b). However, if the oil droplet size would be the 316 
(main) explanation of the increased β-carotene bioaccessibility of the 4% PHC emulsion, it would be 317 
expected that there was a difference between the different durations in the small intestinal phase. 318 
Specifically, the longer lipase can interact with the dietary lipids, the more hydrolysis products could 319 
be released and the more micelles could be formed. Because no significant difference in β-carotene 320 
bioaccessibility with different durations in the small intestinal phase was noticed, it seems that an 321 
equilibrium of the incorporation of β-carotene in the micelles is reached for each emulsion but that 322 
this equilibrium dependents on the phosphatidylcholine concentration. It can be hypothesized that 323 
the 1.0 h incubation time in the small intestinal phase was already sufficiently long to allow all TAGs 324 
present in the initial oil to be digested, irrespective of the oil droplet size. As oil droplet size can not 325 
explain the β-carotene bioaccessibility observations, other hypotheses need to be put forward. 326 
Measuring the phosphatidylcholine concentration in the micellar fraction resulted into the 327 
knowledge that increasing the initial phosphatidylcholine concentration leads to an increasing 328 
concentration in the micellar fraction (results not shown). This leads to the hypothesis that a higher 329 
phosphatidylcholine concentration in the micelles enhances the incorporation of β-carotene due to 330 
solubilisation of β-carotene or that phosphatidylcholine, as a surfactant, improves micelle formation 331 
(Akoh & Min, 2002). In this context, Nishimukai and Hara (2004) observed that the absorption of 332 
lycopene (another lipid-soluble nutrient) increased by adding phosphatidylcholine to soy oil. 333 
Furthermore, Pugnaloni et al. (2004) and Mackie and Wilde (2005) found that there can be a 334 
competitive adsorption between surface active molecules present in the sample (for example 335 
phosphatidylcholine, hydrolysis products or bile acids in this study) which might cause some 336 
displacement on the lipid interfaces. The displacement is dependent on the surface activities of the 337 
different molecules on the one hand but also on the (relative) concentrations on the other hand. The 338 
component with the highest surface activity and concentration will dominate the interface. Also the 339 
micellar electric charge or micelle pH can differ, depending on the molecules present in the micelle, 340 
which can differ the solubility efficiency (Goncalves et al., 2013). These factors can cause that in this 341 
case, the interface of the 1% PHC emulsion can be different than this of the interface of the 2,3 and 342 
4% PHC emulsions, which can explain the different β-carotene incorporation into micelles.  This 343 
observation of different interfaces which may lead to different types of particles is confirmed by the 344 
particle size distributions (Fig. 3), where not only differences between 1% PHC emulsion and 4% PHC 345 
emulsion were shown in particle size but also in particle populations. Whereas the 4% PHC emulsion 346 
contains two different particle population after the small intestinal phase, the 1% PHC emulsion 347 
contains six populations.  348 
A first hypothesis on the link between lipid digestion and β-carotene bioaccessibility is that the same 349 
amount of micelles is formed for all emulsions, thus independent on the phosphatidylcholine 350 
concentration. As a result, the lipid incorporation reached a maximum. On the other hand, the 351 
maximal incorporation of β-carotene in the micelles is not reached yet or is dependent on the 352 
phosphatidylcholine concentration present in the micelles. As phosphatidylcholine might solubilise β-353 
carotene, a higher amount of this emulsifier in the micelles, leads to a higher level of β-carotene 354 
incorporation in the micelles whereas the incorporation of lipids is not affected. Another hypothesis 355 
is that more micelles are formed in the emulsions with more phosphatidylcholine and that some 356 
micelles do not contain MAGs or FFAs so that phosphatidylcholine is used as surfactant in those 357 
micelles. The extra micelles formed with only phosphatidylcholine can incorporate β-carotene as 358 
well, which can explain the higher β-carotene bioaccessibility in emulsions with a higher 359 
phosphatidylcholine concentration (Fig. 6). Finally, because increasing the bile acids concentration 360 
did not lead to an increase of lipid incorporation (results not shown), it seems that the maximum 361 
lipid incorporation into micelles is due to the properties of the micelles, such as the pH, micellar 362 
electric charge (zeta-potential) or surface active compounds. These factors will change by 363 
incorporating compounds thereby affecting the incorporation of other compounds in the micelles 364 
(McClements, Decker, & Park, 2008; Goncalves et al., 2013). 365 
4 Conclusion 366 
This research investigated if it is possible to promote the β-carotene bioaccessibility in food systems 367 
containing the same amount of lipids by influencing the lipid digestion and if there is a clear link 368 
between lipid digestion and β-carotene bioaccessibility. The results show that a higher 369 
phosphatidylcholine concentration in emulsions leads to a higher β-carotene bioaccessibility whereas 370 
the incorporation of lipids into micelles did not increase compared with emulsions with a lower 371 
amount of phosphatidylcholine. It has to be noted however that maximal lipid incorporation into 372 
micelles seems to be reached so that this can be the reason that no clear link can be found between 373 
the lipid digestion and the β-carotene bioaccessibility. The next step in this research can be to study 374 
emulsions where the maximum lipid incorporation into micelles is not reached and to investigate if in 375 
those emulsions a link between β-carotene bioaccessibility and lipid digestion exists. 376 
 377 
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 470 
Fig. 1: Oil droplet size distribution of 1% PHC emulsion (  ), 2% PHC emulsion ( ), 3% PHC emulsion ( ) and 4% PHC 471 
emulsion ( ). 472 
 473 
 474 
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 477 
 478 
Fig. 2: Representative microscopic images of oil droplets in (a) a 1% PHC emulsion and (b) a 4% PHC emulsion. 479 
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 482 
Fig. 3: Particle size distributions of the 1% PHC emulsion (A) and the 4% PHC emulsion (B) before digestion ( ), after 483 
stomach phase (  ) and after small intestinal phase (SIP 1.0 h:  , SIP 1.5 h:  and SIP 2.0 h:  ). 484 
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Fig. 4:  Representative microscopic images of oil droplets in (a) a 1% PHC emulsion and (b) a 4% PHC emulsion after the 486 
stomach phase. 487 
 488 
Fig. 5: Percentage 
𝐿𝑀
𝐿𝑆𝐼𝑃
-values (%) of the different emulsions after 1.0 h SIP ( ), 1.5 h SIP ( ) and 2.0 h SIP ( ), with LM = the 489 
amount of lipids in the micelles per g emulsion and LSIP = the amount of lipids after the small intestinal phase (SIP) per g 490 
emulsion.  Significant differences (Tukey test, P<0.05) are indicated with letters. 491 
 492 
 493 
 494 
Fig. 6: Percentage in vitro β-carotene bioaccessibility (%) for the different PHC emulsions (calculated as the absolute β-495 
carotene bioaccessibility (B) divided by the initial amount of β-carotene (C) in the emulsion)  (mean ± standard deviation) 496 
measured after 1.0 h SIP ( ), 1.5 h SIP ( ) and 2.0 h SIP ( ). Significant differences (Tukey test, P<0.05) are indicated with 497 
different letters (α, β, γ). 498 
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